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Nutritional interventions that target the postoperative and post-discharge periods have 30 
been under investigation for several decades. One of the first randomized controlled trials 31 
(RCT) that used postoperative oral nutritional supplements in patients undergoing major 32 
gastrointestinal surgery saw only 40 of the 54 participants enrolled complete the study [1]. 33 
Participants were randomized to receive a normal ward diet postoperatively or the same 34 
diet supplemented ad libitum by an oral nutritional sip feed commencing from the day they 35 
were adjudged to be capable of ingesting free fluids to the day of discharge. The authors 36 
reported that the mean daily energy and protein intakes were 700 kcal/day (2.9 MJ/day) and 37 
13 g/day greater respectively in the intervention group than in the control group (P<0.0001). 38 
While weight remained stable in the intervention group, those in the control group lost 39 
approximately 5 kg by the time of discharge. Muscle function declined to a greater extent 40 
(P<0.03) and infectious complications were higher (P<0.02) in the control group. 41 
The same group of investigators [2], demonstrated within the setting of a two phase RCT 42 
that initial postoperative oral nutritional supplementation improved nutritional status during 43 
the inpatient period. However, in the post-discharge phase of the trial, continuation of 44 
supplementation for 4 months in the intervention group led to no appreciable differences in 45 
outcomes, including nutritional status, postoperative complications and quality of life. 46 
Nevertheless, at the turn of the 21st century, enteral nutritional supplementation in 47 
malnourished surgical patients during the post-discharge period was shown to lead to 48 
statistically significant improvements in nutritional status, quality of life, and morbidity [3]. 49 
Despite this study [3], and other similar ones subsequently [4], meta-analyses have shown 50 
little or no benefit [5, 6] and doubts still surround the nutritional gain, improvement in 51 
quality of life and the economic benefit of post-discharge oral nutritional supplementation. 52 
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It is, therefore, not surprising that although recommended, post-discharge nutritional 53 
supplementation is not standard care even in the era of enhanced recovery after surgery [7]. 54 
It is now accepted that up to 40% of patients presenting with gastrointestinal cancer will 55 
have a degree of malnutrition and weight-loss, and a smaller proportion will have cancer 56 
cachexia [8]. The preoperative and postoperative periods, therefore, are an obvious target 57 
for nutritional intervention and support. Several RCTs, and recent systematic reviews and 58 
meta-analyses [8, 9] derived from these have pointed to the benefits of specific nutritional 59 
support or interventions during these periods. However, in patients with gastrointestinal 60 
cancer, it is noteworthy that the tumor burden, systemic inflammation, increased basal 61 
metabolic activity and the lack of appetite that ensues potentiate loss of weight and 62 
malnutrition to an extent that is unlikely to be counteracted completely by perioperative 63 
nutritional support alone. Additionally, although these patients often have neoadjuvant and 64 
adjuvant treatments such as chemotherapy, radiotherapy or both, those who are 65 
nutritionally depleted are less likely to tolerate these therapies [10]. Therefore, continuation 66 
of nutritional support and supplementation, beyond the initial preoperative and immediate 67 
postoperative periods, into the post-discharge phase seems an attractive and potentially 68 
important frontier in the nutritional care of patients with gastrointestinal cancer.  69 
The concept of post-discharge nutritional care itself is not novel [2-6]. However, 70 
contemporary studies that have focused on patients with gastrointestinal cancers in 71 
particular are sparse. A recent RCT on 104 participants who underwent surgery for gastric or 72 
colorectal cancer showed that participants receiving post-discharge oral nutritional 73 
supplements had a significant increase in body weight at 60 and 90 days when compared 74 
with controls who received dietary advice alone. However, no differences between groups 75 
4 
were noted in anthropometric measurements, nutrition-related laboratory tests, or quality 76 
of life indicators [11]. It is for this reason that the two RCTs from the same center and using 77 
similar methodology published in this issue of Clinical Nutrition [12, 13], addressing two 78 
distinct gastrointestinal cancers evoke interest. 79 
Gastric cancer and post-discharge nutrition 80 
In this single center, non-blinded RCT, 353 patients were randomized but 337 who 81 
completed the study per protocol were included in the analysis [12]. The intervention group 82 
consisted of 171 participants who received 370 ml of oral nutritional supplements daily with 83 
dietary advice and the control group comprised 166 who received dietary advice alone. 84 
Following 3 months of oral nutritional supplementation, weight loss was significantly less, 85 
and body mass index and skeletal muscle index were significantly higher in the oral 86 
nutritional supplementation group than in the control group (P<0.05). Additionally, although 87 
the prevalence of sarcopenia at baseline was similar in both groups, significantly more 88 
participants in the control group were sarcopenic at three months than those in the 89 
intervention group. However, there were no differences in readmission rates or in the 90 
overall quality of life as defined by the global health status. Nevertheless, specific symptoms 91 
scales, fatigue (P=0.035) and appetite loss (P=0.013) were significantly lower in the 92 
intervention group.  93 
Colorectal cancer and post-discharge nutrition  94 
In the second RCT, 232 participants who underwent surgery for colorectal cancer surgery 95 
were randomized and 212 participants were analyzed per protocol. There were 105 who 96 
received oral nutritional supplements and 107 in the control group [13]. The mean oral 97 
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supplement intake was 410 ml/day. At three months, the skeletal muscle index was 98 
significantly greater in the oral nutritional supplementation group and significantly fewer 99 
participants were sarcopenic than in the control group. However, no significant differences 100 
were found between the two groups in terms of weight, weight loss, body mass index, 101 
serum albumin and hemoglobin concentrations. There was no difference in readmission rate 102 
or quality of life indices. From an economic standpoint, the lack of impact on overall quality 103 
of life and readmission rates renders the intervention difficult to recommend when taken on 104 
its own value.  105 
Critique of the two studies 106 
Although both studies have a relatively large sample size when compared with other similar 107 
studies [1-4, 11], some limitations must be highlighted. The two studies presented were 108 
unblinded trials undertaken by the same research group from the same institution and 109 
reported on a population with predominantly the same ethnicity, thereby limiting their 110 
generalizability. The sample size calculation for the gastric cancer study was based on a 111 
change in weight [12] while that for the colorectal cancer study [13] was based on the 112 
change in skeletal muscle index. It is not clear why the authors chose different end points for 113 
the calculation of sample size in the two studies rather than a single patient-centered 114 
clinically relevant primary end point. Data analysis was on a per protocol rather than an 115 
intention to treat basis. Although the target was 500 ml/day, participants in the intervention 116 
group took a modest 370 ml/day (370 kcal/1.55 MJ and 15.2 g protein) of oral nutritional 117 
supplements in the gastric cancer study [12] and 410 ml/day (410 kcal/1.72 MJ and 16.8 g 118 
protein) in the colorectal cancer study [13]. However, the authors do not provide any 119 
information on the total energy and protein intake in the two groups in each study, which is 120 
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a major limitation for an accurate interpretation of results. In both studies, the major 121 
findings were that postoperative nutritional supplementation diminished the decline in 122 
skeletal muscle index and reduced the proportion of participants with sarcopenia when 123 
compared with the control group. Nevertheless, the actual mean differences at 3 months in 124 
skeletal muscle index between the two groups were quite small (1.6 cm2/m2 in the gastric 125 
cancer study and 1.7 cm2/m2 in the colorectal cancer study). Participants who received oral 126 
nutritional supplements tolerated postoperative chemotherapy better in both studies and 127 
this is an important finding. Although weight loss and consequent decrease in body mass 128 
index were less in the intervention group in the gastric cancer study, there were no 129 
differences between groups in the colorectal cancer study. In addition, there were no 130 
differences between the groups when readmission rates or overall quality of life in both 131 
studies. Nonetheless, these findings could represent some of the marginal gains of post-132 
discharge nutritional supplementation.  133 
Marginal gains theory applied to nutritional supplementation 134 
The marginal gains theory, popularized in the sport of cycling has been advocated in other 135 
competitive sports, aviation, business, and even healthcare [14]. When applied to 136 
perioperative nutrition, it would theoretically be plausible to envisage a scenario where the 137 
known benefits in preoperative nutritional supplementation [8] and enhanced recovery after 138 
surgery principles [7] are augmented by post-discharge nutritional supplementation. The 139 
cumulative effect of the marginal gains on benefit from preoperative, postoperative and 140 
post-discharge nutritional support could result in substantial gains for the individual patient 141 
undergoing surgery for gastrointestinal cancer. This undoubtedly provokes the question – 142 
whether or not, nutritional intervention studies should be undertaken in isolation or in 143 
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combination – to exploit the potential benefits and marginal gains of preoperative, 144 
postoperative and post-discharge nutritional care. Moreover, patient partnership and 145 
education is important for cooperation and compliance and this is easier done in the time 146 
waiting for an operation than in the postoperative period. 147 
Future directions 148 
The European Society for Clinical Nutrition (ESPEN) recommends the use of appropriate 149 
post-discharge nutritional support therapy for surgical patients including those with cancer 150 
at risk of malnutrition [15-18], but there is a dearth of high-quality evidence underpinning 151 
these consensus recommendations. Although these two new studies [12, 13] add to the 152 
body of evidence, there is a need for larger multicenter studies, with appropriate sample size 153 
calculations based on patient-centered clinically relevant primary outcome measures, from 154 
mixed population groups, with staggered duration of post-discharge supplementation and 155 
variations in the oral supplements themselves, to allow us to fully assess, appreciate, 156 
generate and disseminate the evidence base on post-discharge nutritional supplementation. 157 
Importantly, these studies should be conducted to take advantage of and incorporate 158 
enhanced recovery after surgery protocols so that patients are provided the best possible 159 
care package.   160 
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